A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2009
12/31/2009	US20090325942 Phenothiazin derivates, method for the production thereof and use thereof as pharmaceuticals
12/31/2009	US20090325932 4-piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
12/31/2009	US20090325930 Selective estrogen receptor modulator
12/31/2009	US20090325924 GPCR Agonists
12/31/2009	US20090325896 Partial and full agonists of a1 adenosine receptors
12/31/2009	US20090325872 Use of alpha-lactalbumin for regulations of glycemia
12/31/2009	US20090325865 Liquid Formulations of Pegylated Growth Hormone
12/31/2009	US20090324758 Plant extract mixtures and their uses
12/31/2009	US20090324750 Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
12/31/2009	US20090324701 Compositions containing (s)-bethanechol and their use in the treatment of insulin resistance, type 2 diabetes, glucose intolerance and related disorders
12/31/2009	US20090324637 Process for producing a stable concentrated dietary supplement and supplement produced thereby
12/31/2009	US20090324625 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/31/2009	US20090324605 Interferon alpha antibodies and their uses
12/31/2009	US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
12/31/2009	US20090324598 Method for the treatment of inflammatory disorders
12/31/2009	US20090324537 Polymeric Materials as Stomach Filler and Their Preparation
12/31/2009	US20090324502 Nasal Formulations of Insulin
12/30/2009	WO2009158467A2 Di-substituted phenyl compounds
12/30/2009	WO2009158412A2 Sustained delivery of exenatide and other polypeptides
12/30/2009	WO2009158031A2 Methods and compositions for therapeutic treatment
12/30/2009	WO2009157562A1 Method for establishment of adult pancreatic stem cell, and method for differentiation of adult pancreatic stem cell
12/30/2009	WO2009157559A1 Pancreatic cell regeneration/transplantation kit for pancreatic diseases or diabetes
12/30/2009	WO2009157418A1 Carboxylic acid compound
12/30/2009	WO2009157013A1 Protein based product from fenugreek seeds that regulates dyslipidemia and obesity, and a process for the preparation thereof
12/30/2009	WO2009156860A2 Substituted triazinone derivatives
12/30/2009	WO2009156796A1 Pharmaceutical compositions of rosuvastatin calcium
12/30/2009	WO2009156484A2 Organic compounds
12/30/2009	WO2009156479A1 Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
12/30/2009	WO2009155936A1 Use of hsp70 as a regulator of enzymatic activity
12/30/2009	WO2009155753A1 The use of inositol derivative or salts thereof in the manufacture of medicaments as glycosidase inhibitors or medicaments for treating diabetes
12/30/2009	WO2009155693A1 Improved turfgrass fungicide formulation with pigment
12/30/2009	WO2009155676A1 Rosmarinic acid from origanum vulgare for treatment of diabetes
12/30/2009	WO2009155669A1 Method of treatment of vascular complications
12/30/2009	WO2009155637A1 Protocols for treating and preventing obesity and complications arising therefrom
12/30/2009	WO2009134380A3 Super fast-acting insulin compositions
12/30/2009	WO2009133458A4 Pharmaceutical composition comprising extracts of huanglian and ku ding cha effective for lowering blood lipid levels
12/30/2009	WO2009130422A3 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
12/30/2009	WO2009106708A3 Azetidine derivatives, their preparation and their application in therapy
12/30/2009	WO2009062118A3 Modulation of protein trafficking
12/30/2009	EP2138497A1 Novel adenine compound
12/30/2009	EP2138495A1 Substituted pyrimido[2,1-a]isoquinolin-4-one derivatives
12/30/2009	EP2138489A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
12/30/2009	EP2138488A1 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases
12/30/2009	EP2138484A1 Fused bicyclic heteroaryl derivatives
12/30/2009	EP2138190A2 Compositions comprising dietary fat complexer and methods for their use
12/30/2009	EP2138183A1 Ameliorating or prophylactic agent for metabolic syndrome, and beverage, food and feed each comprising the same
12/30/2009	EP2138176A1 Method of treating cognitive impairment
12/30/2009	EP2138175A2 Formulations comprising valsartan for treating diabetes or microalbuminuria
12/30/2009	EP2137531A2 Biased ligands for receptors such as the pth receptor
12/30/2009	EP2137175A1 Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
12/30/2009	EP2136637A1 Inhibitors of cholesterol ester transfer protein
12/30/2009	EP2049525B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
12/30/2009	EP1620395B1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
12/30/2009	EP1532149B1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
12/30/2009	EP1523541B1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
12/30/2009	EP1501498B1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan
12/30/2009	EP1490047B1 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/30/2009	EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis
12/30/2009	EP1430019B1 Sphingolipids
12/30/2009	EP1307108B1 Oil/fat composition
12/30/2009	EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof
12/30/2009	CN201372259Y Manufacturing system extracting chitosan of antibiotic peptide substance from maggots
12/30/2009	CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/30/2009	CN101613310A Method of preparing amine stereoisomers
12/30/2009	CN101612402A Interferon antagonist and use of Flt3L interferon
12/30/2009	CN100575361C Humanized single chain antibody for anti-human cytomegalovirus envelope glycoprotein
12/30/2009	CN100574765C A medicine for treating hyperphosphatemia disease and iron deficiency anemia disease
12/30/2009	CN100574638C Compound containing DAG and the method for preparing the same
12/30/2009	CA2766282A1 Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
12/30/2009	CA2729327A1 Organic compounds
12/30/2009	CA2729242A1 Improved turfgrass fungicide formulation with pigment
12/30/2009	CA2729220A1 Di-substituted phenyl compounds
12/30/2009	CA2729115A1 Substituted triazinone derivatives
12/30/2009	CA2728735A1 Compositions and methods for enhanced somatostatin immunogenicity
12/30/2009	CA2728539A1 Pharmaceutical compositions of rosuvastatin calcium
12/30/2009	CA2728363A1 Use of hsp70 as a regulator of enzymatic activity
12/30/2009	CA2727340A1 Carboxylic acid compound
12/30/2009	CA2726894A1 Therapeutic agents comprising elastin-like peptides
12/30/2009	CA2725930A1 Methods for treating visceral fat conditions
12/29/2009	US7638643 Process for producing soybean saponin-containing material
12/29/2009	US7638607 Urocortin proteins and uses thereof
12/29/2009	US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009	US7638546 Imidazolyl derivatives
12/29/2009	US7638524 For reducing serum cholesterol in a mammal
12/29/2009	US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
12/29/2009	US7638520 Pyrimidine compounds
12/29/2009	US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
12/29/2009	US7638490 For treating anorexia or cachexia
12/29/2009	US7638141 Generating multipotent cells from sstem cells isolated from residual cord blood; tissue engineering and regenerative medicine
12/29/2009	CA2480125C Use of carbon-2-modified-19-nor-vitamin d analogs to induce the formation of new bone
12/29/2009	CA2466490C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/29/2009	CA2465877C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
12/29/2009	CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/29/2009	CA2415683C Indoloquinazolinones
12/29/2009	CA2411760C 2-aminothiazoline derivatives and their use as no-synthase inhibitors
12/29/2009	CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/29/2009	CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
12/29/2009	CA2345369C Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use
12/29/2009	CA2264802C Antioxidant derived from lentil and its preparation and uses
12/24/2009	US20090318567 Lycopene for the treatment of metabolic dysfunction

1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 1298